a primer on us due diligence and disclosure standards applied in rule 144a offerings
DESCRIPTION
With the welcome increase of IPO activity in the UK over the past few months, combined with the renewed prospect of accessing investors in the US capital markets, this Travers Smith briefing revisits some essential US regulatory concepts that may have been overlooked in the wake of the financial crisis.There are two threshold issues that arise under US federal securities laws in an offering of securities to investors in the US:(i) in the absence of a statutorily available exemption, it is unlawful to offer or sell a security to investors within the US unless a registration statement has been filed with, and declared effective by, the SEC; and(ii) when offering a security for sale to investors within the US, it is unlawful to do so by means of fraud, misrepresentation or deceit.With regard to the first issue, this briefing focuses on private offerings of securities into the US which are underwritten by one or more investment banks and offered (a) on the basis of an offering document prepared by the company issuing the securities, the underwriters and their respective advisers and (b) pursuant to a statutorily available exemption (in this case, a Rule 144A Offering).The aim of this briefing is to deal with the second issue, however, by providing a summary description of the anti-fraud provisions under US federal securities laws and explaining the concepts and standards of "due diligence" and "disclosure" in the context of a Rule 144A Offering.TRANSCRIPT
1
A Primer on U.S. Due Diligence
and Disclosure Standards Applied
in Rule 144A Offerings
With the welcome increase of IPO activity in the United Kingdom over the past few months, combined with the
renewed prospect of accessing investors in the U.S. capital markets, we thought it might be helpful to revisit
some essential U.S. regulatory concepts that, because of the financial crisis that began in 2008, many market
participants may have either gleefully forgotten or blissfully never confronted.
Introduction
To begin, there are two threshold issues that arise under the U.S. federal securities laws (defined below) in an offering of
securities to investors in the United States:
(i) in the absence of a statutorily available exemption, it is unlawful to offer or sell a security to investors within the United
States unless a registration statement has been filed with, and declared effective by, the SEC; and
(ii) when offering a security for sale to investors within the United States, it is unlawful to do so by means of fraud,
misrepresentation or deceit.
With regard to the first issue, we will limit our discussion in this primer to private offerings of securities into the United States
which are underwritten by one or more investment banks ("underwriters") and offered (a) on the basis of an offering document
(a "prospectus") prepared by the company issuing the securities (the "issuer"), the underwriters and their respective advisers
and (b) pursuant to a statutorily available exemption (in this case a "Rule 144A Offering"1).
The aim of this primer is to deal with the second issue, however, by providing a summary description of the anti-fraud provisions
under the U.S. federal securities laws and explaining the concepts and standards of "due diligence" and "disclosure" in the
context of a Rule 144A Offering.
Sources of Applicable U.S. Federal Law
The body of U.S. federal law2 that generally regulates securities offerings in the United States, as well as the activities of due diligence
and disclosure, comprises the following:
(i) the U.S. Securities Act of 1933, as amended (the "Securities Act") and the rules, regulations and guidelines promulgated
thereunder;
(ii) the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules and regulations promulgated
thereunder;
(iii) the rulemaking, interpretations and guidance provided by the U.S. Securities and Exchange Commission3 (the "SEC");
(iv) U.S. federal case law.
For the purpose of this primer, (i), (ii), (iii) and (iv), set out above, shall together be referred to as the "U.S. federal securities laws".
1 Securities Act Rule 144A is an exemption from registration under the Securities Act for the resale of securities to qualified institutional buyers "QIBs" (as
defined in Rule 144A) in the United States. In private placements into the United States, it is common practice for investment banks to agree both to procure subscribers for (pursuant to a reasonable efforts placement under Section 4(a)(2) of the Securities Act and/or Regulation D thereunder) and, failing that, to subscribe for themselves (a firm underwriting), the securities being offered. Rule 144A allows the underwriters to resell such underwritten securities, and is often used as a shorthand description of the U.S. offering.
2 This note does not address the securities laws, or "blue sky" laws, of the individual U.S. states.
3 The stated mission of the SEC is, among other things, to protect investors, maintain fair, orderly and efficient markets, and facilitate capital formation.
2
General Anti-Fraud Rule
Exchange Act Rule 10b-5 is one of several iterations of the general anti-fraud principles under the U.S. federal securities laws and, as
we explain below, it is applicable to Rule 144A Offerings. Rule 10b-5 provides that "[i]t shall be unlawful for any person, directly or
indirectly, by use of any means or instrumentality of interstate commerce, or of the mails, or of any facility of any national securities
exchange, (a) to employ any device, scheme, or artifice to defraud, (b) to make any untrue statement of a material fact or to omit to
state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made,
not misleading, or (c) to engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon
any person, in connection with the purchase or sale of any security."
It would be fair to say that the language underlined in (b) above is less than eloquent; however, the SEC and federal court judges have
generally agreed that the statutory language makes it unlawful knowingly or recklessly to offer and/or sell a security to an investor in
the United States through fraud, misrepresentation or deceit in a prospectus or in any other form of communication. The prohibition set
out in Exchange Act Rule 10b-5 can be applicable, under the right circumstances, to any person, anywhere.4
Prospectus Liability
Depending on the circumstances of a Rule 144A Offering (e.g., primary or secondary offering), if an investor (or the SEC) alleges a
violation of the antifraud rules in a prospectus, it could bring an action against one or more of the following persons or entities involved
in the preparation of a prospectus:
• the issuer of the securities;
• the selling shareholder;
• persons controlling the issuer;
• directors and certain officers of the issuer;
• experts providing expert information in a prospectus (e.g., accountants or appraisers);
• underwriters; and
• certain others who may have participated in the preparation of a prospectus.
Origins of the "Due Diligence Defence" in a Rule 144A Offering
Under the U.S. federal securities laws, the fraud statutes are applied principally on the basis of a determination whether a securities
offering is public or private.5 In public offerings, the U.S. federal securities laws impute strict liability on the issuer unless it can show
that the plaintiff knew of the material misstatement or omission giving rise to the cause of action at the time of the acquisition of the
security in question; however, other persons or parties (including underwriters, controlling persons, directors and officers and any
selling shareholder ("eligible defendants")) may avoid liability if they can prove the following:
• With regard to any information in the prospectus that was not provided by an expert, such person had, after reasonable
investigation, reasonable grounds to believe, and did believe, that the information was true, accurate and complete in all material
respects6;
• With regard to information in the prospectus provided by an expert, such person (other than the expert) had no reasonable grounds
to believe, and did not believe, that such information was untrue, inaccurate or incomplete in any material respect.7
In light of the burden of proof set out above, market participants involved in U.S. public offerings developed the "due diligence
defence," the purpose of which being to demonstrate, in a cause of action brought against an eligible defendant, that such defendant
had conducted a reasonable investigation and had otherwise conducted itself reasonably under the circumstances.
Because Rule 144A Offerings are private offerings, plaintiffs must rely on Exchange Act Rule 10b-5 to allege securities fraud. The
federal courts have, however, held that such plaintiffs may not rely merely on a determination that the issuer or other eligible
4 In 2010, the U.S. Supreme Court held in Morrison Et Al. v. National Australia Bank Ltd. Et Al., 130 S. Ct. 2869 (2010) that Section 10(b) and Rule 10b-5
under the Exchange Act apply only to purchases and sales of securities in the United States. The holding limits the extraterritorial application of the U.S. antifraud laws in so-called "foreign cubed" cases where, formerly, redress may have been available for non-U.S. plaintiffs suing U.S. and non-U.S. defendants in relation to a non-U.S. securities transaction on the basis either (i) that the securities fraud had an effect on the United States or on U.S. persons, or (ii) that a significant and material part of the fraudulent conduct occurred in the United States. Please note, however, that the holding by the U.S. Supreme Court does not appear in any way to impair the application of Section 10(b) or Rule 10b-5 to conduct that these laws explicitly prohibit.
5 In 1995, the U.S. Supreme Court held in Gustafson v. Alloyd, 513 U.S. 561 (1994) that Section 12(2) of the Securities Act applies only to a prospectus used
in connection with a public offering of securities in the United States. In addition, Section 11 of the Securities Act applies solely to registration statements filed with the SEC and Section 17 is not available for private causes of action.
6 Paraphrasing Securities Act Section 11(b)(3)(A)
7 Paraphrasing Securities Act Section 11(b)(3)(C)
3
defendants have failed to meet the burden of proof applicable in public offerings, as set out above; they must also affirmatively show
that such defendants knowingly or recklessly made the misstatement or omission (proving so-called "scienter").8 Recklessness has
been defined by U.S. federal courts as "an extreme departure from the standards of ordinary care […] which presents a danger of
misleading buyers or sellers that is either known to the defendant or is so obvious that the defendant must have been aware of it."9
In light of the higher burden of proof set by the U.S. federal courts in the application of Rule 10b-5, many market participants outside
the United States concluded in the mid-1990's that the "due diligence defence" was not necessary in Rule 144A Offerings. That
misapprehension was appropriately dispelled by the U.S. securities bar, which recognized the strong likelihood that a U.S. federal
judge would find a way to impute liability under Rule 10b-5 to underwriters who offer and sell securities in the United States "without
knowing, or apparently caring, whether the disclosures regarding those securities are accurate,"10
as surely such behaviour would be
regarded as reckless. As a result, and despite the higher burden of proof in Rule 10b-5 liability cases, underwriters, market participants
and the U.S. securities bar will normally prepare the prospectus in a Rule 144A Offering applying the same standard of due diligence
and disclosure that is found in offerings registered with the SEC.
No Small Comfort?
Because of its critical role as intermediaries between the issuer and the securities markets and investors, an underwriter's reasonable
investigation must be extensive, more so perhaps than any other eligible defendant. As a consequence, the due diligence process,
described more fully below, has been developed by and among underwriters, U.S. legal counsel, independent accountants/auditors
and other experts. In particular, as market practice has evolved, underwriters have required that certain parties provide written
"comfort" to support their due diligence defence:
• "10b-5 letters" (sometimes called "negative assurance" or "disclosure" letters) are provided by U.S. securities lawyers engaged by
the issuer and the underwriter. A 10b-5 letter provides generally that nothing has come to the attention of the U.S. securities lawyer
that would cause her or him to believe that the prospectus is not accurate and complete in all material respects. A 10b-5 letter can
only be given by U.S. counsel, however, if: (i) fulsome management and documentary due diligence has been conducted on the
issuer's group with the involvement of the U.S. securities lawyers, (ii) the U.S. securities lawyers have been involved in the drafting
and vetting of the prospectus and, most importantly, (iii) nothing has, in fact, come to the U.S. lawyer's attention that would cause
her or him to believe that the prospectus is not complete and accurate in all material respects; and
• "Comfort letters" are provided by the issuer's independent accountant/auditors and generally state that: (i) they are independent,
(ii) they have audited year-end (and perhaps interim) consolidated financial statements of the issuer and, under certain
circumstances (iii) they may also have subjected interim consolidated financial statements to limited review, reviewed certain
principal line items in the issuer's consolidated financial statements prepared by the issuer for periods subsequent to the interim
period and spoken with certain officials of the issuer about such financial information. Under those circumstances, the comfort letter
would also then indicate whether anything has come to the independent auditor's attention to cause it to believe that (a) any
material amendment to the interim financial statements is necessary or the interim financial statements do not conform with the
applicable accounting principles, or (b) such principal line items have changed materially since the date of the last audit or limited
review.
It is nevertheless incumbent upon the underwriters to conduct their own reasonable investigation of the issuer and its group companies
(e.g., its business, results of operations, financial condition, prospects and operating and legal risks), as the SEC and federal courts
warn against undue reliance on 10b-5 letters or comfort letters, and even on information provided by experts, such as an audit
opinion11
. It is, in fact, not entirely clear to what extent a 10b-5 letter and/or a comfort letter would constitute a significant part of a due
diligence defence; but the involvement of U.S. securities lawyers and the issuer's independent accountants in the due diligence and
disclosure process is viewed by market participants as a key component of best practice.
Due Diligence and Disclosure Defined
Therefore, the term "due diligence" embodies the obligation under the U.S. federal securities laws of any underwriter, controlling
person or any selling shareholder, director or officer of an issuer and certain other individuals engaged in the preparation of an offering
document to conduct a reasonable investigation of the issuer and its group companies (e.g., its business, results of operations,
financial condition, prospects and operating and legal risks).
8
Ernst & Ernst v. Hochfelder, 425 U.S. 185 (1976) 9 Franke v. Midwestern Okla. Dev. Auth., 428 F. Supp. 719, 725 (W.D. Okla. 1976)
10 David W. Bernstein, "Due Diligence and the Legacy of Gustafson" in International Financial Law Review (August 1995).
11 For a fairly recent and thorough explanation of the duty of underwriters to conduct a reasonable investigation, see In re Worldcom, Inc. Securities Litigation,
346 F. Supp.2d 628 (S.D. New York 2004)
4
The U.S. federal securities laws provide that, for the purposes of determining what constitutes a reasonable investigation, the standard
of reasonableness shall be that required of a prudent man in the management of his own property—but as mentioned above, the
underwriter's role as intermediary between the issuer and the securities markets and investors, as well as its level of sophistication and
experience, mean that the reasonableness of its behaviour will very likely be heavily contextualized by a U.S. federal judge.
The term "disclosure" refers to any information that is provided by an issuer, its subsidiaries or affiliates, and any of its or their directors,
officers, employees or agents, to potential investors, current shareholders or bondholders, securities analysts, the press, or to any
regulatory body or stock exchange in the context of a securities offering or in the context of ongoing regulatory compliance. The
principal disclosure document in the context of an offering of securities is the prospectus, in which underwriters may also provide a very
limited amount of information relating to their legal names, business names, addresses and roles in the Rule 144A Offering (this is
sometimes referred to as "blood letter" information).
Conducting Due Diligence and Proper Disclosure in a Rule 144A Offering
As a preliminary matter, it is important to establish parameters by which the issuer, its subsidiaries and other affiliates, its or their
directors, officers and employees (the "Issuer's Group") can facilitate the disclosure of all material information to the underwriters,
underwriters' counsel, issuer's counsel, the auditors and any other party engaged for the purpose of preparing the prospectus and,
more generally, for the purpose of conducting a Rule 144A Offering (together with the Issuer's Group, the "Working Group").
The disclosure of material information by the Issuer's Group generally occurs under the following circumstances:
• the preparation, maintenance and updating of a documentary "data room" until the completion of the transaction;
• the participation in meetings and discussions with the Working Group (kick-off meetings, management presentations and
management due diligence meetings, drafting sessions and conference calls) where matters relating to the Rule 144A Offering, the
securities, the business, results of operations, financial condition, material economic and other contractual relationships and
business risks relating to the Issuer's Group and the prospectus are disclosed and discussed; and
• the preparation, drafting, review, amendment, verification and updating (and perhaps even supplementing) of the prospectus.
Identifying Material Information
Under the U.S. federal securities laws, a fact is material if there is a substantial likelihood that proper disclosure of that fact would have
been viewed by a reasonable investor as having significantly altered the "total mix" of information made available to the investor at the
time the investment decision was made. This is a "qualitative" evaluation that is difficult to apply at the beginning of the Rule 144A
Offering, when many parties in the Working Group may know very little about the Issuer's Group.
As a practical solution to assist the due diligence process, and in part based on standards applied by the accounting profession and
guidance provided by the SEC12
, market participants have developed a "quantitative" threshold by which materiality may be determined
on a preliminary basis. However, the quantitative threshold is put in place solely to facilitate the preparation and updating of the data
room and the ongoing management due diligence. At the end of the day, the qualitative determination of what information is material,
as defined in the preceding paragraph, governs the detail and depth of disclosure that must be provided in the prospectus in order to
meet the standards established by the U.S. federal securities laws.
The documents that should be prepared for review should regard any obligation (or series of related obligations), occurrence (or series
of related occurrences), or agreement (or series of related agreements) that, individually or in the aggregate, has a value or impact
(potential or actual) that exceeds the materiality threshold described below.
It is possible that documents that do not meet such threshold may nevertheless be material because they contain information that a
buyer or seller of the company’s shares would want to know, or if known, would affect the market value of the shares. For example,
facts, circumstances or documents that reflect on the integrity of key managers or that would restrict or prohibit the company from
selling company shares or conducting its business may be material regardless of the amounts involved. In addition, debt obligations will
be relevant if they exceed any cross-default thresholds in the Issuer Group’s primary lending agreements, and change of control
clauses or clauses otherwise triggered by the contemplated securities offering may be material.
• Material Documents
For most issuers, a general rule of thumb is to consider 5% of pre-tax income as the overall materiality threshold. Given that the
disclosure in the prospectus must contain all material information, generally speaking, the documents reviewed in connection with the
diligence exercise should be limited to “material” documents only. Therefore, with respect to contracts, assets or liabilities (including tax
12 See 17 CFR Part 211 [Release No. SAB 99] SEC Staff Accounting Bulletin No. 99
5
or other litigation, environmental liabilities, etc.), the review is generally limited to those that, unless otherwise material, exceed the
quantitative materiality threshold.
Counsel for the underwriters normally will furnish the issuer with a document request list that indicates what documents are being
sought. It is likely that such a request list will be geared to the particular business activity or activities that the issuer is engaged in, and
will be guided by precedent securities offerings by comparable businesses. Such lists may not, however, specifically request all
documents that may be material to the issuer's business, so it will be incumbent upon the Issuer's Group to help guide the
documentary review in such instances.
Finally, with respect to the period of review, it is generally expected that materials for the Group’s last three full fiscal years and for the
interim period subsequent to the full fiscal year, through the closing of the offering, should be made available (n.b. there may be some
circumstances where the look-back period should be up to 5 years).
• Material Subsidiaries
A general rule of thumb is to treat Issuer Group companies as material for the purposes of the due diligence if their contribution to the
Issuer Group is greater than 5% of either total assets or pre-tax income on a consolidated basis. The due diligence exercise will most
likely need to include documentation from such companies.
Disclosing Material Information: Sources of Form and Substance
There are a number of sources in the U.S. federal securities laws that provide guidance on what information is required to be disclosed
in a prospectus, and how such information is required to be disclosed, principal among which are the following:
• Regulation S-X, which provides guidance on the disclosure of financial information in a prospectus;
• Regulation S-K, which provides guidance on the contents of a prospectus, including a description of the business and the securities
of the issuer, the presentation of certain financial information, disclosure on management and certain security holders, and risk
factors;
• Industry Guides 3 through 7 under the Securities Act (dealing generally with disclosure on bank holding companies, oil and gas
programs, real estate, insurance and mining, respectively);
• Form 20-F, which is used by foreign private issuers who file a registration statement with, or report annually to, the SEC;
• The Plain English Rules under the Securities Act, which provide those preparing a prospectus with guidance on diction and the
presentation of information concisely and clearly; and
• SEC guidance on drafting risk factors and the Operating and Financial Review section of a prospectus.
In the preparation of a prospectus in a Rule 144A Offering, some or all of these resources may have to be taken into consideration in
order to meet the disclosure standards under the U.S. federal securities laws.
Conclusion
The due diligence and disclosure process in a Rule 144A Offering is iterative, requires a significant commitment of time and effort from
all members of the Working Group and has been known to engender no small measure of consternation in certain circumstances. We
believe, however, that given the high level of securities litigation in the United States, the evolving liability thresholds and the
willingness of U.S. federal courts to ensure that underwriters observe standards of behaviour that support the legislative intent of the
U.S. antifraud rules, the process will continue to be worthwhile.
If you require any further details, please contact Charles Casassa or Dan McNamee.
Travers Smith LLP 10 Snow Hill London EC1A 2AL T: +44 20 7295 3000 F: +44 20 7295 3500 www.traverssmith.com
Charles Casassa
Tel: 020 7295 3202
Email: [email protected]
Dan McNamee
Tel: 020 7295 3492
Email: [email protected]
Travers Smith LLP is a limited liability partnership registered in England and Wales under number OC 336962 and is regulated by the Solicitors Regulation Authority. The word "partner" is used to refer to a member of Travers Smith LLP. A list of the members of
Travers Smith LLP is open to inspection at our registered office and principal place of business: 10 Snow Hill, London, EC1A 2AL. We are not authorised under the Financial Services and Markets Act 2000 but we are able, in certain circumstances, to offer a limited
range of investment services because we are members of the Law Society of England and Wales and regulated by the Solicitors Regulation Authority. We can provide these investment services if they are an incidental part of the professional services we have been
engaged to provide. The information in this document is intended to be of a general nature and is not a substitute for detailed legal advice.